SCANDINAVIA’S NEXT LEADER IN CANCER AND INFLAMMATION

 

Nuevolution AB (publ) is a biopharmaceutical company listed on NASDAQ Stockholm (NUE.ST), focused on developing drug treatments for human diseases within immuno-oncology, oncology and inflammatory diseases. Nuevolution is the inventor of Chemetics®, a patent protected drug discovery platform, which enables efficient discovery of novel small molecule drug candidates for specific indications addressing disease targets within the company’s therapeutic focus areas. In this section, you can find information about Nuevolution’s share price, news flow and other information relevant to our listing.

 

ShareGraph2

 

EventCalendar

 

NewsStand

 

CorporateGovernanceParagraph

 

GeneralMeeting

 

Library2